These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 208328)

  • 1. [Rational method of obtaining sera with a high titre of virus-neutralizing antibodies. Report 2].
    Kravchenko AT; Omel'chenko TN; Tsetlin EM
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):31-6. PubMed ID: 208328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rational method of producing sera with high titers of virus neutralizing antibodies].
    Kravchenko AT; Tsetlin EM; Omel'chenko TN
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):41-5. PubMed ID: 190829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rational method for producing sera with high titers of virus-neutralizing antibodies. Part III].
    Kravchenko AT; Tsetlin EM; Omel'chenko TN
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):50-4. PubMed ID: 6254289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine.
    Horie H; Sato M; Doi Y; Hashizume S
    Vaccine; 1996 Jan; 14(1):35-41. PubMed ID: 8821647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistence of latex agglutination inhibition antibodies in rabbits following application of poliomyelitis-, Coxsackie-, Echo- and encephalomyocarditis viruses. Brief report].
    Schmidt WA; Brade H; Klein M
    Arch Virol; 1975; 47(3):291-4. PubMed ID: 164163
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3.
    van der Marel P; Hazendonk TG; Henneke MA; van Wezel AL
    Vaccine; 1983 Dec; 1(1):17-22. PubMed ID: 6099638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
    Jarzabek Z; Kańtoch M
    Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of methods for obtaining high-titer antispirochete sera].
    Lozeva T; Ivanov P
    Vet Med Nauki; 1975; 12(4):39-42. PubMed ID: 1216681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
    Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
    J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of poliovirus neutralizing antibodies in young adult women.
    Mayer TR; Balfour HH
    JAMA; 1981 Sep; 246(11):1207-9. PubMed ID: 6267329
    [No Abstract]   [Full Text] [Related]  

  • 11. [Formation and persistence of latex-agglutination-inhibiting IgG- and IgM-antibodies in rabbits inoculated with poliomyelitis, Coxsackie and encephalomyocarditis viruses (author's transl)].
    Brade H; Klein M; Schmidt WA
    Zentralbl Bakteriol Orig A; 1975 Oct; 233(2):139-46. PubMed ID: 175613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Findings of virus-neutralizing antibodies against polioviruses in the population of Slovakia 9 and 12 years following introduction of immunization by attenuated polioviruses (author's transl)].
    Borská K; Mayerová A; Masár I; Svanigová L; Roda J; Lukácová V
    Bratisl Lek Listy; 1976 Apr; 65(4):400-6. PubMed ID: 183864
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant effects of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and aluminium hydroxide on neutralizing antibody, antibody-isotype and delayed-type hypersensitivity responses to Semliki Forest virus in mice.
    Katz D; Lehrer S; Galan O; Lachmi BE; Cohen S
    FEMS Microbiol Immunol; 1991 Nov; 3(6):305-20. PubMed ID: 1812932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.
    Guérin N; Bregère P; Caudrelier P; Raynaud O
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):815-6. PubMed ID: 9923532
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibody production against poliovirus N and H antigens by immunization of guinea pigs].
    Mietens C; Fuhrmeister U
    Arch Gesamte Virusforsch; 1971; 34(1):23-31. PubMed ID: 4329437
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enhancing the immunogenicity of inactivated polio vaccines with chitosan used as an adjuvant].
    Gendon IuZ; Markushin SG; Akopova II; Krivtsov GG; Akhmatova NK; Koptiaeva IB; Vasil'ev IuM
    Vopr Virusol; 2011; 56(6):28-32. PubMed ID: 22359946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of linear and cyclic peptides of neutralization antigenic site 1 of poliovirus type 1 to induce virus cross-reactive and neutralizing antibodies.
    van der Werf S; Briand JP; Plaué S; Burckard J; Girard M; Van Regenmortel MH
    Res Virol; 1994; 145(6):349-59. PubMed ID: 7535942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A micrometabolic inhibition test for the estimation of poliovirus neutralizing antibodies.
    Kyriazopoulou VG; Bell EJ
    Bull World Health Organ; 1972; 47(2):171-5. PubMed ID: 4345395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the dynamics of herd immunity to the poliovirus and of the quality of the vaccination carried out against poliomyelitis].
    Vlasova LV; Vaserin IuI; Stepanova GP; Zakirova SF; Venediktova NIa
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):75-8. PubMed ID: 6303022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficient rabbit immunization schemes for obtaining diagnostic sera against adenoviruses].
    Kravchenko AT; Omel'chenko TN; Tsetlin EM
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Apr; (4):90-3. PubMed ID: 7080767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.